Mark Hyman Rapaport (Mark Rapaport)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

High Resolution Mass Spectrometry

Placebo Controlled

Top Venues

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Emory University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Emory University Sep 15 2011

United States

Professor and Chair :: Psychiatry &Behavioral Sciences

Publications

Stefania Lamon-Fava, Minying Liu, Boadie W Dunlop, Becky Kinkead, Pamela J Schettler, Jennifer C Felger, Thomas R Ziegler, Maurizio Fava, David Mischoulon, Mark Hyman Rapaport
Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2023)
Kathrin LaFaver, William Curt LaFrance, Michele E Price, Phyllis B Rosen, Mark Hyman Rapaport
Treatment of functional neurological disorder: current state, future directions, and a research agenda. CNS spectrums (2020)
Karen S Rommelfanger, Mark Hyman Rapaport
An agenda for functional neurological disorders: care and research. CNS spectrums (2020)